Stocks
GlaxoSmithKline (GSK) Operating Income US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| Operating Income, £ | 6 201 000 000 | 6 433 000 000 | 6 433 000 000 | 6 563 000 000 | 6 993 000 000 | 6 036 000 000 | |||
| Changes by years, y/y, % | 0% | +4% | 0% | +2% | +7% | +5.0% | |||
GlaxoSmithKline. Operating Income, £
GlaxoSmithKline. Operating Income, changes, %
GlaxoSmithKline. Operating Income, sum by quarters, £
GlaxoSmithKline (GSK) Operating Income US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| Operating Income, £ | 2 141 000 000 | 1 949 000 000 | 1 052 000 000 | 1 052 000 000 | 1 983 000 000 | 6 036 000 000 | ||
| Changes by years, y/y, % | +98% | +64% | -44% | -44% | -5% | |||
| Changes by quarters, q/q, % | 0% | -9% | -46% | 0% | +88% | |||
